Fast-track to UK market: Mastering the MHRA's recognition procedure

Regulatory-blog-image_100x100.jpgThis audiogram is part of The Regulatory Navigator series, where we explore the evolving regulatory landscape with actionable insight from Parexel's experts, sharing their experience to maximize success for clinical development and patient access.

The MHRA's International Recognition Procedure (IRP) is transforming medicines licensing and creating unprecedented opportunities to accelerate your product's journey to market. This game-changing pathway could dramatically reshape your global submission strategy.

Get the insider advantage. Our team of former MHRA regulators reveals exclusive insights to help you:

 

  • Fast-track your authorization process
  • Strategically optimize your global submission sequence
  • Gain competitive edge in market entry timing
     

Return to Insights Center

Related Insights

Blog

Accelerate global drug development: Navigating China's evolving pharmaceutical regulatory landscape

Sep 4, 2025

Blog

Assessing the need for comparative clinical trials in biosimilar development programs

Sep 21, 2023

Playbook

Mitigating risk, protecting potential: Practical strategies that position cell and gene therapy development for success

Mar 28, 2023

Report

New Medicines, Novel Insights: Advancing rare disease drug development

May 22, 2023

Report

New Medicines, Novel Insights: Accelerating development of cell and gene therapies

May 22, 2023

Webinar

Assessing appropriate use of ECAs in clinical trials

May 28, 2023

Blog

Celebrating 40 Years of Rare Disease Progress: WODC Highlights

Jun 6, 2023

Blog

Population variability: important considerations in vaccine development

Jun 14, 2023

Whitepaper

How to prepare for Policy 0070: Challenges and opportunities for clinical data publication in the EU

Jun 28, 2023

Article

The technologies that are reshaping biotherapeutics manufacturing, an EU perspective

Jul 6, 2023

Blog

Ensuring future success in a new market by delivering a robust safety database solution

Aug 4, 2023

Whitepaper

Optimizing the Route to Regulatory Approval for a Novel Vaccine

Aug 18, 2023

Related Insights

Blog

Accelerate global drug development: Navigating China's evolving pharmaceutical regulatory landscape

Sep 4, 2025

Blog

Assessing the need for comparative clinical trials in biosimilar development programs

Sep 21, 2023

Playbook

Mitigating risk, protecting potential: Practical strategies that position cell and gene therapy development for success

Mar 28, 2023

Report

New Medicines, Novel Insights: Advancing rare disease drug development

May 22, 2023

Report

New Medicines, Novel Insights: Accelerating development of cell and gene therapies

May 22, 2023

Webinar

Assessing appropriate use of ECAs in clinical trials

May 28, 2023

Show more